As previously reported, Morgan Stanley analyst Erin Wright downgraded Heska to Underweight from Equal Weight with a price target of $58, down from $135. She already had viewed Heska’s medium-term and long-term outlook as "ambitious," but underperformance in 2022 and slower than anticipated traction with its new Element AIM launch are "inevitably disappointing" and add risk to 2023 growth, Wright tells investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HSKA:
- Dalan Animal Health granted USDA conditional license for honeybee vaccine
- Heska price target lowered to $165 from $170 at Piper Sandler
- Heska price target lowered to $119 from $155 at Alliance Global Partners
- Heska sees FY22 revenue in line with FY22 and up 5%
- Heska reports Q4 non-GAAP EPS 41c, consensus (11c)